ArticleProceedings of the National Academy of Sciences of the United States of America2021

A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells.

Matthew Mahoney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.